Accutane is a medication with the active ingredient isotretinoin. It is also known by other names like Roaccutane and Claravis. Accutane is mainly used to treat severe acne that hasn’t improved with other treatments.
For Accutane, the expenditure spectrum spans from £0.45 to £4.99 per pills. Cost fluctuations are based on packaging proportions and the potency of core components (10 or 360 mg).
Accutane, also known by its generic name isotretinoin, is primarily indicated for the treatment of severe recalcitrant nodular acne. It is prescribed for patients who have not responded to other conventional treatments, including antibiotics. Accutane may also be used off-label for other conditions as determined by a healthcare provider.
Accutane works by reducing sebaceous gland size and sebum production, which plays a critical role in acne development. Additionally, it normalizes the process of keratinization, reducing hyperkeratinization and thus preventing the formation of comedones. Accutane also exhibits anti-inflammatory properties which help in reducing severe acne lesions.
Accutane is absorbed in the gastrointestinal tract with enhanced absorption when taken with food. It undergoes extensive hepatic metabolism and has a half-life of approximately 10-20 hours. The drug is primarily eliminated via the feces, with some renal excretion. The pharmacokinetics may vary depending on the dosing regimen and individual patient factors.
Accutane is contraindicated in pregnant women due to the high risk of teratogenicity. It is also contraindicated in patients with hypersensitivity to isotretinoin or any of its excipients. Caution is advised in patients with hepatic insufficiency, hyperlipidemia, and those taking concomitant tetracyclines due to an increased risk of intracranial hypertension.
Accutane may interact with other medications affecting its efficacy or increasing the risk of adverse effects. Concomitant use with vitamin A supplements should be avoided due to the risk of additive toxicity. Use with tetracyclines may increase the risk of pseudotumor cerebri. Alcohol consumption should be moderated as it may exacerbate liver toxicity.
Accutane should be taken with a meal to enhance absorption. It is typically started at a dose of 0.5 to 1 mg/kg/day, divided into two doses. The dose can be adjusted based on clinical response and tolerance, not exceeding 2 mg/kg/day. Treatment duration usually spans 15-20 weeks, with some patients requiring a second course after a drug-free interval.
Common adverse reactions to Accutane include dryness of the skin, lips, and mucous membranes. Patients may also experience peeling of the palms and soles, pruritus, epistaxis, and conjunctivitis. Psychiatric symptoms, though rare, can include mood swings and depression. Laboratory abnormalities such as elevated liver enzymes and hyperlipidemia may also occur.
Regular monitoring is crucial while on Accutane therapy. Monthly pregnancy tests are mandatory for female patients of childbearing potential. Baseline and periodic liver function tests and lipid profiles should be conducted. Assess patients for signs of depression or mood changes. Regular dermatologic assessments will track treatment progress and side effects.
Educate patients on the importance of adhering to the prescribed dosing regimen and not sharing the medication with others. Advise on the use of emollients and lip balms to manage dryness. Inform patients to avoid waxing and dermabrasion procedures during and for six months post-treatment due to the risk of scarring. Recommend the use of sunscreen and protective clothing to avoid photosensitivity reactions.
Accutane should be stored at room temperature away from light and moisture. Dispense the medication in a child-resistant container. Healthcare providers should wear gloves and adhere to standard safety protocols when handling Accutane capsules to avoid unintentional exposure. Any unused medication should be properly disposed of in accordance with local regulations.